Kinnevik AB (publ)
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed April 28, 2025), Kinnevik AB (publ) reported 1 stock position worth $71.1 million. Its top holding was Recursion Pharmaceuticals-A (RXRX) at 100.0% of the portfolio. Compared with Q4 2024, it added to 1. The biggest buy was Recursion Pharmaceuticals-A (RXRX, shares +13%).
- Most Recent 13F
- Q3 2025
- Location
- STOCKHOLM, V7
- CIK
- 0001766574
- Portfolio Value
- $71.1M (Q1 2025)
- SEC Filing
- 0001104659-25-040213 ↗ filed Apr 28, 2025
Holdings Value
Holdings 1 stocks · $71.1M
| RXRX Recursion Pharmaceuticals-A | 100.00% | 13,434,171 | $71.1M | Add +12.8% |
Portfolio Sells Q4 2024 → Q1 2025
| None this quarter. | |||
Portfolio Buys Q4 2024 → Q1 2025
| RXRX Recursion Pharmaceuticals-A | Add +12.8% | 100.00% | 0.00 |